Thursday 15 December 2016

EMMA LAWTON CAN SMILE AGAIN!

Do you know that the Seed of greatness in you makes you an inventor and can help put a smile on others faces? The article below is an astounding story of Haiyan Zhang, an inventor who brought smiles to the face of Emma Lawton, a 33-year-old suffering from Parkinson disease. What an amazing story! Read with me and like Haiyan, think of how you can help someone put an end to their suffering or pain by inventing something that will help them.


Cambridge inventor helps Parkinson's disease sufferer to write again
The graphic designer appeared on The Big Life Fix on BBC2 this week.



A woman with early-onset Parkinson’s disease will be able to write her name again thanks to a Cambridge engineer’s invention.
Emma Lawton, 33, was diagnosed with early-onset Parkinson’s disease in 2012. The symptoms cause involuntary tremors which mean Emma is unable to even write her own name. As a graphic designer, this caused her a lot of trouble.

Now, Emma has teamed up with Cambridge inventor, Haiyan Zhang, Innovation Director at Microsoft Research Cambridge, who is attempting to design a device that will allow Emma to overcome the tremors and write again.
Emma appeared on The Big Life Fix with Simon Reeve on BBC2 on Wednesday.
The emotional programme followed the pair as they worked to complete a wearable wristband device which allowed Emma to write and draw for the first time in three years.

The device shakes and deliberately disrupts the wearer’s arm, forcing their brain to adapt and allowing them to counteract the involuntary shaking of the arm.
The invention appeared to be a success and there were emotional scenes as Emma was able to write her name for the first time in years.
Asked about the viability of the device for other patients, Haiyan said more work needed to be done to ascertain whether the device could work for other patients, but that she was “amazed” with how well it had worked for Emma.




Wednesday 7 December 2016

I CAN DO ALL THINGS BECAUSE I AM BORN TO BE GREAT!


There seem to be more areas we can delve into, meaning that all the solutions for this world to be as 'great' as God intended it to be, is not given yet. There is a solution inside of you; it is hidden in your seed of greatness.  You have what it takes, stop waiting for others to do something. Be inspired, think deeply and find areas you can be a solution too. Join the crew, help to bring a change, help to make lives better, help to bring greatness to our world. You could add an icing on the cake in your sphere. We all have what it takes!

Read with me, read between the lines, ask yourself the question, what can I do? Look within; the answer is inside of you!



How IBM's Watson supercomputer is battling cancer with advanced genomics


By 

 




Back in 2003, when he was a fourth year medical student at Washington University in St. Louis looking at a career in oncology, Lukas Wartman was diagnosed with acute lymphoblastic leukemia. For Wartman, the diagnosis was bleak – while this type of leukemia, which affects the blood and bone marrow, is very treatable for children, it often proves fatal for adults. Two years of chemotherapy followed and Wartman went into remission and completed his medical studies. The reprieve was short-lived. By 2008, he relapsed again.


During this second relapse Wartman was approached by The Genome Institute about being part of a research study to have his entire genome sequenced.  Through careful analysis of Wartman’s RNA, it was found that a gene known as FLT3 was found in a higher level than average. Sutent, a drug that targets the FLT3 gene for people who have kidney cancer, was determined to be the best course of treatment. Wartman went into remission for a third time. He is now cancer free, and it is safe to say that genomics saved Wartman’s life.


For Wartman, a doctor who is perhaps even more acutely aware of the effectiveness of genomics research than others, the announcement that IBM Watson would be partnering with 14 leading cancer institutes to advance genomics research resonated strongly. Wartman, who serves as the assistant director of cancer genomics at Washington University’s McDonnell Genome Institute, was on hand May 5 at the first annual World of Watson event in Brooklyn, New York to help announce the new partnership.


As with much of the work that IBM’s cognitive computing system has been participating in – Watson has dipped its toes into everything from education to cooking — this new genomics initiative marks a way to leverage big data to simplify an often complex process, such as making personalized cancer diagnoses.


According to IBM’s press release, the genome for one patient equals about 100 gigabytes of data. It’s a vast amount of information for a human doctor to sift through. With Watson quickly analyzing this information, IBM executives view this as being one of the cornerstones of the broader Watson Health initiative.


“Together, we will change the face of healthcare,” IBM CEO Ginni Rometty proudly declared during the World of Watson event in the Brooklyn Navy Yard.
For Wartman, who started having informal conversations with IBM upon hearing about Watson’s move into the health sector, the response to this new program has been “overwhelmingly positive.”


“Moving forward, I think now it’s time for us to show that we can use this platform successfully, get away from the hype, and get the evidence to show that this is effective,” Wartman told FoxNews.com. “This is a great first step.”


Wartman said that the ability to have easily accessible vast amounts of data that can be used – in a HIPAA-compliant way – to shed light on a disease that manifests itself so differently individual-to-individual is game-changing.


While Watson — with its boundless capacity to learn more and more information – sounds like the ultimate medical professional, Wartman asserted that the computer is not a replacement for doctors.


“This technology is not meant to replace the high standard of care that we already have,” he said. “We are going to learn from this sequencing technology and be able to provide much better prognostic information.”


It is unusual for a patient to survive three relapses as Wartman has, and he acknowledged that many “aren’t as lucky as I have been” and that, hopefully through this technology, “more people can be treated more successfully.”


How can Watson help do this? Wartman suggested that by having a more intimate understanding of each patient’s genetic code, doctors will be able to find more out-of-left-field drugs to target specific cancers. Just as Sutent was deemed the best treatment for Wartman by looking at his RNA, the idea is that Watson can help more physicians make similarly targeted prognoses for more patients.


Over the past few decades, technological advances in medicine have made lightning-fast strides. When Wartman was first treated 12 years ago, he said that the protocol used to battle leukemia didn’t vary much from what was “cutting edge” decades before.


“From a decade ago to now, doctors now have this amazing turnaround time when it comes to interpreting results – it’s tremendously exciting,” Wartman added.


The real end-goal for this kind of development is to make this genetic data as widely available as possible. Essentially, it isn’t just reserved for the big, elite medical institutions like the one in which Wartman both works and was treated. He said that this cognitive computing technology “needs to play an important role in helping to bring this (information) to the wider population.”


For cancer survivors and patients, optimism is always tempered by the fact that “cancer is a really, really, tough disease,” according to Wartman.


“This sequencing technology — using these analytic platforms — gives us a better opportunity to make headway against cancer than ever before,” Wartman said. “Now is the time that we need to think about how we can stay in the fight against cancer, the war against cancer, and keep pushing forward and find ways to continue to make significant improvements in the way we are treating patients.”

http://www.foxnews.com/tech/2015/05/14/how-ibms-watson-supercomputer-is-battling-cancer-with-advanced-genomics.html


I FIND THIS INTRIGUING

Interestingly, we have different passions and that which excites us. Perhaps and in most cases, this may be a clue to knowing the seed of greatness inside of you. You may just be that person who feels like something leaps inside of you when you see certain things or ills in the society. Many people are lovers of things for the wrong reasons, but a good number, however, are drawn to what they love or excites them because it has something to do with the area they have the ability to make an improvement in or could create something that can change the world in.

For car lovers, I thought this would excite you. Not really to bring you just excitement but to bring to your reminder that while many people are still asleep, consuming what great people are doing or are letting their seed of greatness waste away, some have their hands on deck and are doing tremendously well to bring comfort to those they are meant to serve.

What can I create, you may ask? As you pray and ponder on the answer, join me to appreciate the work of those who build out automobile.

New cars 2017 - pictures



1. The hot Abarth 500X will inject a bit of fizz into the 500X mini-suv lineup



2. Reviving the Alpine brand name is going to be a big risk for Renault



3. The next Aston Martin V8 Vantage will benefit from a Mercedes engine, but keep its stunning British design

4.  The next generation Audi A6 Allroad is likely to closely resemble this Prologue Allroad concept from 2015


5.Expect a hi-tech revolution for the next-generation Audi A8 luxury saloon 



6. One of the best-selling models in the company's range, the new Audi Q5 is vital for the company's continued success


7. With no roof and a glorious non-turbo 5.2-litre V10 in the back, the new Audi R8 Spyder should sound epic


8. The new Audi Q2 has only just arrived, but already a high-performance SQ2 is in the pipeline


9.The Audi TT RS is very nearly as fast as the R8 supercar, but costs a fraction of the price

10.The forthcoming BMW i5 crossover is the next step towards the company's zero-emmission future

11. Another new SUV, the BMW X2 is a coupe-esque crossover based on the current BMW X1

 12.The next BMW Z4 will share much with the forthcoming Toyota Supra


13.This larger Citroen SUV will be building on the success of the funky Citroen C4 Cactus


14. The newest Ferrari GTC4Lusso gets turbocharged V8 power and rear-wheel drive only


15. The next-generation Ford Fiesta is getting more expensive, more premium and more hi-tech for 2017


16. This latest Honda Civic is expected to be a giant leap forward compared to the current model


 17. The next Hyundai i30 promises more tech and higher build quality than ever before. There'll be a hot 'N' version, too


18.The Infiniti Q60 is a handsome left-field alternative to the Mercedes C-Class Coupe and BMW 4 Series


19.The Jeep Compass will be taking on the likes of the Nissan Qashqai & SEAT Ateca when it arrives towards the end of 2017

20.The new Audi A5 Sportback adds an extra dose of practicality to the slinky A5 Coupe range


http://www.carbuyer.co.uk/new-cars-2017- last browsed on 8.12.16